Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 70.7

(-3.42%)

Market Cap (In TWD)

3.17 Billion

Revenue (In TWD)

606.71 Million

Net Income (In TWD)

79.7 Million

Avg. Volume

61.2 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
61.2-91.6
PE
-
EPS
-
Beta Value
-0.389
ISIN
TW0004747001
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Pai-Hsiung Huang
Employee Count
-
Website
https://www.jcpjohnson.com.tw
Ipo Date
2012-06-28
Details
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.